Bokkers K, Frederix GWJ, Velthuizen ME, van der Aa M, et al. Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective. Gynecol Oncol 2022 Aug 25. pii: S0090-8258(22)00550.
PMID: 36031452